BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
0.860
-0.160 (-15.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed

BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $1.37 million. The enterprise value is -$1.55 million.

Market Cap 1.37M
Enterprise Value -1.55M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date May 14, 2026
Ex-Dividend Date n/a

Share Statistics

BiomX has 1.59 million shares outstanding. The number of shares has increased by 115.25% in one year.

Current Share Class 1.59M
Shares Outstanding 1.59M
Shares Change (YoY) +115.25%
Shares Change (QoQ) +21.02%
Owned by Insiders (%) 22.46%
Owned by Institutions (%) 17.04%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.87

Current Ratio 0.87
Quick Ratio 0.70
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,546.00

Financial Efficiency

Return on equity (ROE) is -316.90% and return on invested capital (ROIC) is -114.13%.

Return on Equity (ROE) -316.90%
Return on Assets (ROA) -78.85%
Return on Invested Capital (ROIC) -114.13%
Return on Capital Employed (ROCE) 5,187.92%
Weighted Average Cost of Capital (WACC) 7.21%
Revenue Per Employee n/a
Profits Per Employee -$1.81M
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BiomX has paid $7,000 in taxes.

Income Tax 7,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.59% in the last 52 weeks. The beta is 1.70, so BiomX's price volatility has been higher than the market average.

Beta (5Y) 1.70
52-Week Price Change -92.59%
50-Day Moving Average 4.09
200-Day Moving Average 6.42
Relative Strength Index (RSI) 19.15
Average Volume (20 Days) 214,444

Short Selling Information

The latest short interest is 78,198, so 4.91% of the outstanding shares have been sold short.

Short Interest 78,198
Short Previous Month 93,010
Short % of Shares Out 4.91%
Short % of Float n/a
Short Ratio (days to cover) 0.75

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -30.92M
Pretax Income -36.19M
Net Income -36.20M
EBITDA -28.00M
EBIT -30.92M
Earnings Per Share (EPS) -$22.19
Full Income Statement

Balance Sheet

The company has $4.36 million in cash and $1.44 million in debt, giving a net cash position of $2.92 million or $1.83 per share.

Cash & Cash Equivalents 4.36M
Total Debt 1.44M
Net Cash 2.92M
Net Cash Per Share $1.83
Equity (Book Value) -1.30M
Book Value Per Share -12.50
Working Capital -804,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.39 million and capital expenditures -$2,000, giving a free cash flow of -$26.39 million.

Operating Cash Flow -26.39M
Capital Expenditures -2,000
Depreciation & Amortization 2.92M
Net Borrowing n/a
Free Cash Flow -26.39M
FCF Per Share -$16.56
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -115.25%
Shareholder Yield -115.25%
Earnings Yield -2,641.13%
FCF Yield -1,925.60%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 25, 2025. It was a reverse split with a ratio of 1:19.

Last Split Date Nov 25, 2025
Split Type Reverse
Split Ratio 1:19

Scores

Altman Z-Score n/a
Piotroski F-Score 1